Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets
Marcelo N. N. Vieira, Ricardo A. S. Lima-Filho, Fernanda G. De Felice
Neuropharmacology (2017) Vol. 136, pp. 160-171
Closed Access | Times Cited: 119

Showing 1-25 of 119 citing articles:

Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Stephen C. Cunnane, Eugenia Trushina, Cecilie Morland, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 9, pp. 609-633
Open Access | Times Cited: 683
The Role of Leptin and Adiponectin in Obesity-Associated Cognitive Decline and Alzheimer’s Disease
Letícia Forny‐Germano, Fernanda G. De Felice, Marcelo Nunes do Nascimento Vieira
Frontiers in Neuroscience (2019) Vol. 12
Open Access | Times Cited: 225
VDAC1, mitochondrial dysfunction, and Alzheimer's disease
Varda Shoshan‐Barmatz, Edna Nahon-Crystal, Anna Shteinfer‐Kuzmine, et al.
Pharmacological Research (2018) Vol. 131, pp. 87-101
Closed Access | Times Cited: 211
Insulin Resistance in Alzheimer's Disease
Laís S. S. Ferreira, Caroline Fernandes, Marcelo N. N. Vieira, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 193
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
Henry Querfurth, Hankyu Lee
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 186
Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer’s Disease
Yanan Sun, Cao Ma, Hui Sun, et al.
Journal of Diabetes Research (2020) Vol. 2020, pp. 1-12
Open Access | Times Cited: 139
Obesity as a Risk Factor for Dementia and Alzheimer’s Disease: The Role of Leptin
Juan Antonio Flores-Cordero, Antonio Pérez‐Pérez, Carlos Jiménez‐Cortegana, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5202-5202
Open Access | Times Cited: 128
Type 2 Diabetes Mellitus and Alzheimer’s Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets
Rim Hamzé, Etienne Delangre, Stefania Tolu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15287-15287
Open Access | Times Cited: 94
Antidiabetic agents as a novel treatment for Alzheimer’s and Parkinson’s disease
Joseph Nowell, Eleanor G Blunt, Dhruv Gupta, et al.
Ageing Research Reviews (2023) Vol. 89, pp. 101979-101979
Open Access | Times Cited: 84
The GLP-1 Agonist Semaglutide Ameliorates Cognitive Regression in P301S Tauopathy Mice Model via Autophagy/ACE2/SIRT1/FOXO1-Mediated Microglia Polarization
Norhan N. Elbadawy, Muhammed A. Saad, Sara Elfarrash, et al.
European Journal of Pharmacology (2025), pp. 177305-177305
Closed Access | Times Cited: 2
Brain insulin resistance: role in neurodegenerative disease and potential for targeting
Christian Hölscher
Expert Opinion on Investigational Drugs (2020) Vol. 29, Iss. 4, pp. 333-348
Open Access | Times Cited: 137
Intranasal insulin in Alzheimer's disease: Food for thought
Colin D. Chapman, Helgi B. Schiöth, Claudia A. Grillo, et al.
Neuropharmacology (2017) Vol. 136, pp. 196-201
Open Access | Times Cited: 95
Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review
Jorge Berlanga‐Acosta, Gerardo Guillén, Nadia Rodríguez-Rodríguez, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 93
Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease
Steven N. Austad, Scott W. Ballinger, Thomas W. Buford, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 511-531
Open Access | Times Cited: 57
Bioactivity of natural biflavonoids in metabolism-related disease and cancer therapies
José C. J. M. D. S. Menezes, Marc Diederich
Pharmacological Research (2021) Vol. 167, pp. 105525-105525
Closed Access | Times Cited: 56
Molecular mechanisms underlying hyperglycemia associated cognitive decline
Mrinal Gupta, Shivani Pandey, Mohammad Rumman, et al.
IBRO Neuroscience Reports (2022) Vol. 14, pp. 57-63
Open Access | Times Cited: 53
Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus
Maria Chiara Pelle, Isabella Zaffina, Federica Giofrè, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11301-11301
Open Access | Times Cited: 31
Diabetes Mellitus as a Risk Factor for Parkinson’s Disease: a Molecular Point of View
Alice Biosa, Tiago F. Outeiro, Luigi Bubacco, et al.
Molecular Neurobiology (2018) Vol. 55, Iss. 11, pp. 8754-8763
Closed Access | Times Cited: 66
Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice
Miren Ettcheto, Amanda Cano, Patrícia Regina Manzine, et al.
Molecular Neurobiology (2019) Vol. 57, Iss. 4, pp. 1814-1827
Closed Access | Times Cited: 60
Abnormal gut microbiota composition contributes to cognitive dysfunction in streptozotocin-induced diabetic mice
Yu Fan, Wei Han, Gaofeng Zhan, et al.
Aging (2019) Vol. 11, Iss. 10, pp. 3262-3279
Open Access | Times Cited: 55
Evaluating the beneficial effects of dietary restrictions: A framework for precision nutrigeroscience
Kenneth A. Wilson, Manish Chamoli, Tyler Hilsabeck, et al.
Cell Metabolism (2021) Vol. 33, Iss. 11, pp. 2142-2173
Open Access | Times Cited: 48
Role of DPP-4 and SGLT2 Inhibitors Connected to Alzheimer Disease in Type 2 Diabetes Mellitus
Adelene Y. L. Sim, Sumit Barua, Jong Youl Kim, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 44
Interorganelle communication, aging, and neurodegeneration
Maja Petković, Caitlin E. O’Brien, Yuh Nung Jan
Genes & Development (2021) Vol. 35, Iss. 7-8, pp. 449-469
Open Access | Times Cited: 43
Remembering your A, B, C's: Alzheimer's disease and ABCA1
Cutler T. Lewandowski, Megan S. Laham, Gregory R. J. Thatcher
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 3, pp. 995-1018
Open Access | Times Cited: 33
Experimental Type 2 diabetes and lipotoxicity-associated neuroinflammation involve mitochondrial DNA-mediated cGAS/STING axis: implication of Type-1 interferon response in cognitive impairment
Preeti Kumari, Anika Sood, Valencia Fernandes, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 6217-6244
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top